Retension Pharmaceuticals
About Retension Pharmaceuticals
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series B T: - FT: Series B |
A: 15000000 MR: - FA: $15 Million FAN: 15000000 |
D: 2025-08-06 FD: 2025-08-06 |
- |
| 2 |
RT: Series A T: - FT: Series A |
A: 10400000 MR: - FA: 10.4 million FAN: 10400000 |
D: 2024-08-21 FD: 2024-08-21 |
1 investors |
Growth Metrics
Team & Leadership
Elliot Ehrich
Senior Medical Advisor
Enoch Kim
Head of Chemistry
Dhanapalan Nagarathnam
Head of CMC
Susan Alpert
Regulatory Advisor/FDA
Michael Berendt
Board Chair
Eric Keller
Chief Executive Officer, Founder & Chairman
Recent News
Retension Pharmaceuticals Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- retensionpharmaceuticals.com
- Industries
- Biopharmaceutical
- Company Size
- ~340 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro